Kim Brian S, Miyagawa Fumi, Cho Young-Hun, Bennett Clare L, Clausen Björn E, Katz Stephen I
Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Invest Dermatol. 2009 Dec;129(12):2805-17. doi: 10.1038/jid.2009.176. Epub 2009 Jun 25.
The precise contribution(s) of skin dendritic cells (DCs) to immune responses in the skin has not been well delineated. We developed an intradermal (i.d.) injection model in which CD8+ T (OT-I) cells that express ovalbumin (OVA) peptide-specific TCRs (Valpha2/Vbeta5) are delivered directly to the dermis of transgenic (Tg) mice expressing OVA in the epidermis. After i.d. injection, these mice reliably develop skin graft-versus-host disease (GVHD) by day 7. To determine the relative contribution of Langerhans cells (LCs) to the ensuing GVHD-like reaction, we generated K14-OVA x Langerin-diphtheria-toxin-receptor (Langerin-DTR) Tg mice to allow conditional ablation of LCs in the epidermis. To delineate the role of dermal DCs (dDCs) in the reaction, we also generated K14-OVA Tg chimeras using beta(2)-microglobulin-deficient (beta(2)m) congenic donor bone marrow cells. Dermal DCs in these mice cannot present OVA to autoreactive T cells (OT-I cells), whereas the LCs are antigen presentation-competent. Unexpectedly, OT-I cell injection into diphtheria toxin (DT)-treated beta(2)m --> K14-OVA x Langerin-DTR Tg mice resulted in skin GVHD. Thus, in vivo, both LC and dDC appear to be dispensable for the induction of keratinocyte-directed, CD8-mediated effector immune responses. Furthermore and surprisingly, OVA-expressing epidermal cells depleted of LCs that could not initiate allogeneic epidermal lymphocyte reactions activated naive OT-I cells in vitro. These results indicate that keratinocytes may function as accessory cells competent to prime naive skin-reactive T cells.JID JOURNAL CLUB ARTICLE: For questions, answers, and open discussion about this article, please go to http://network.nature.com/group/jidclub.
皮肤树突状细胞(DCs)对皮肤免疫反应的确切贡献尚未得到很好的描述。我们开发了一种皮内(i.d.)注射模型,其中表达卵清蛋白(OVA)肽特异性TCRs(Valpha2/Vbeta5)的CD8 + T(OT-I)细胞被直接递送至在表皮中表达OVA的转基因(Tg)小鼠的真皮。皮内注射后,这些小鼠在第7天可靠地发生皮肤移植物抗宿主病(GVHD)。为了确定朗格汉斯细胞(LCs)对随后的GVHD样反应的相对贡献,我们生成了K14-OVA x Langerin-白喉毒素受体(Langerin-DTR)Tg小鼠,以允许在表皮中条件性消融LCs。为了阐明真皮DCs(dDCs)在反应中的作用,我们还使用β2-微球蛋白缺陷(β2m)同基因供体骨髓细胞生成了K14-OVA Tg嵌合体。这些小鼠中的真皮DCs不能将OVA呈递给自身反应性T细胞(OT-I细胞),而LCs具有抗原呈递能力。出乎意料的是,将OT-I细胞注射到经白喉毒素(DT)处理的β2m→K14-OVA x Langerin-DTR Tg小鼠中导致了皮肤GVHD。因此,在体内,LC和dDC似乎对于诱导角质形成细胞定向的、CD8介导的效应免疫反应都是可有可无的。此外,令人惊讶的是,耗尽了LCs的表达OVA的表皮细胞不能引发同种异体表皮淋巴细胞反应,但在体外激活了幼稚的OT-I细胞。这些结果表明角质形成细胞可能作为能够启动幼稚皮肤反应性T细胞的辅助细胞发挥作用。《皮肤病学研究杂志》期刊俱乐部文章:有关本文的问题、答案和公开讨论,请访问http://network.nature.com/group/jidclub。